Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Recommendation of “Hold” from Brokerages

Shares of Henry Schein, Inc. (NASDAQ:HSIC) have been given an average recommendation of “Hold” by the twelve brokerages that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, six have given a hold recommendation and five have issued a buy recommendation on the company. The average 12-month target price among brokers that have covered the stock in the last year is $76.4167.

A number of equities research analysts have recently commented on HSIC shares. Wells Fargo & Company lifted their price objective on Henry Schein from $70.00 to $76.00 and gave the company an “equal weight” rating in a research report on Wednesday, November 5th. Mizuho set a $81.00 price target on Henry Schein and gave the company a “neutral” rating in a report on Tuesday, January 20th. Wall Street Zen upgraded shares of Henry Schein from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Henry Schein in a research report on Monday, December 29th. Finally, Barrington Research set a $79.00 price target on shares of Henry Schein and gave the stock an “outperform” rating in a research report on Wednesday, November 5th.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. CYBER HORNET ETFs LLC purchased a new stake in Henry Schein during the second quarter valued at about $25,000. MUFG Securities EMEA plc acquired a new position in shares of Henry Schein in the 2nd quarter valued at about $27,000. Flagship Harbor Advisors LLC purchased a new stake in shares of Henry Schein during the 4th quarter worth about $30,000. Federated Hermes Inc. acquired a new stake in Henry Schein during the 4th quarter worth approximately $32,000. Finally, Los Angeles Capital Management LLC purchased a new position in Henry Schein in the fourth quarter valued at approximately $37,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Up 3.6%

HSIC stock opened at $79.57 on Friday. The company has a 50 day moving average price of $77.37 and a two-hundred day moving average price of $71.64. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.79 and a current ratio of 1.40. The stock has a market capitalization of $9.37 billion, a P/E ratio of 25.18, a PEG ratio of 2.37 and a beta of 0.88. Henry Schein has a one year low of $60.56 and a one year high of $82.80.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.